CBOT
Corgi Robots & Humanoids ETF
The Corgi Robots & Humanoids ETF seeks to provide investors with exposure to companies involved in the development and production of robotic and humanoid technologies.
US
EQUITY
Active
MANAGEMENT STYLE
$ 1.5 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | May 05, 2026 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| NVIDIA CORP | 14.5 % |
| ALPHABET INC. CLASS A | 11.3 % |
| UIPATH INC CLASS A | 5.7 % |
| COGNEX CORP | 5.5 % |
| AURORA INNOVATION, INC. CLASS A | 5.4 % |
| TESLA MOTORS INC | 5.2 % |
| AMAZON.COM INC | 5.1 % |
| INTUITIVE SURGICAL INC | 4.6 % |
| NOVANTA INC | 4.5 % |
| CATERPILLAR INC | 4.0 % |
Constituent Breakdown
| Number of holdings | 24 |
| Herfindahl-Hirschman Index | 643 |
| Wgt avg mkt cap (mns) | $1,501,860 |
| Large cap (>$10bn) | 51.5% |
| Mid cap ($2-10bn) | 38.9% |
| Small cap (<$2bn) | 9.4% |
| Developed mkts. | 99.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 99.8 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -- | -- | -- | -- | -- | -- | -- | -7.6% |
| Dividend Yield | -- | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | -- | -- | -- | -- | -- | -- | -- | -7.6% | Ann. Volatility | -- | -- | -- | -- | -- | -- | -- | 27.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 3.1% |
| Avg. Bid/Ask (% of price) | 0.22% |
Technical Indicators
| 30d moving avg. (EMA) | $24.95 |
| Relative strength (RSI) | 55 |
| MACD/Signal | 0.35/0.12 |
| Bollinger Bands (Upper/Lower) | $26.72/$22.36 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CBOT |
Expenses vs. CBOT |
ALTAR Score™ vs. CBOT |
|---|---|---|---|---|
| LRND | IQ U.S. Large Cap R&D Leaders ETF | 31.2% | -21 bp | +5.4% |
| XLG | Invesco S&P 500 Top 50 ETF | 30.0% | -15 bp | +5.2% |
| EGUS | iShares ESG Aware MSCI USA Growth ETF | 29.8% | -17 bp | +5.1% |
| PJFG | PGIM Jennison Focused Growth ETF | 29.8% | +40 bp | +3.2% |
| FBCG | Fidelity Blue Chip Growth ETF | 29.6% | +24 bp | +4.3% |
| RND | First Trust Bloomberg R&D Leaders ETF | 29.6% | +25 bp | +4.9% |
| CABZ | Roundhill Robotaxi Autonomous Vehicles & Technology ETF | 29.4% | +24 bp | -0.8% |
| LRGE | ClearBridge Large Cap Growth ESG ETF | 29.0% | +24 bp | +4.4% |
| VUSG | Vanguard Wellington U.S. Growth Active ETF | 28.9% | 0 bp | +4.0% |
| ARKQ | ARK Autonomous Technology & Robotics ETF | 28.8% | +40 bp | +0.7% |
Risk and Returns: CBOT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 10/23/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.1%
ALTAR SCORE™
1st
PERCENTILE
AVOID
ETFRC RATING
There are 1,393 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. CBOT's ALTAR Score™ is approximately -2.7 standard
deviations above the category average. This places CBOT in the 1st percentile
among funds in the category.
Sell-Side Consensus
$31.36
PRICE TARGET
+38.9%
UPSIDE